Pimasertib

Generic Name: Pimasertib

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₁₅FIN_₃O_₃

CAS Number: 1236699-92-5

Unique Ingredient Identifier: 6ON9RK82AL

Background: Pimasertib is under investigation in clinical trial NCT01378377 (Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025

The biotech sector in 2024 saw initial gains erased by setbacks, yet attracted investors with innovations in obesity, immunology, and gene therapy. Immunocore Holdings, Allogene Therapeutics, and Day One Biopharmaceuticals, despite stock declines, are poised for recovery in 2025 due to anticipated regulatory approvals and pipeline progress.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy